Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Phase I Study of a New Tuberculosis (TB) Vaccine, MVA85A, in Healthy Volunteers With HIV

This study has been completed.
Sponsor:
Collaborator:
Centre Hospitalier Universitaire Le Dantec, Dakar, Senegal
Information provided by:
University of Oxford
ClinicalTrials.gov Identifier:
NCT00731471
First received: August 6, 2008
Last updated: March 25, 2011
Last verified: March 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: January 2011
  Primary Completion Date: January 2011 (Final data collection date for primary outcome measure)
No publications provided by University of Oxford

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):